Inhibition and induction of glutathione S-transferases by flavonoids: Possible pharmacological and toxicological consequences

Drug Metabolism Reviews

Volumn 44, Issue 4, 2012, Pages 267-286

  Boušová, Iva ^a   Skálová, Lenka ^a  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

Author keywords

Cytostatics; Detoxification; Dietary supplement; Drug flavonoid interaction; GST

Indexed keywords

2 HYDROXYCHALCONE; APIGENIN; BETA NAPHTHOFLAVONE; BUTEIN; CATECHIN; CHALCONE DERIVATIVE; EPIGALLOCATECHIN GALLATE; ERIODICTYOL; FISETIN; FLAVANOL DERIVATIVE; FLAVANONE DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; FLAVONOLIGNAN; GALANGIN; GALLOCATECHIN GALLATE; GLUTATHIONE TRANSFERASE; ISOFLAVONE DERIVATIVE; KAEMPFEROL; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MORIN; MYRICETIN; POLYPHENOL; POLYPHENON E; PROTOAPIGENON; QUERCETIN; SILIBININ; TANNIN; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

AMINO TERMINAL SEQUENCE; ANTIOXIDANT ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; DIET SUPPLEMENTATION; DRUG STRUCTURE; ENZYME ACTIVE SITE; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME SUBUNIT; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN DOMAIN; REVIEW;

ANIMALS; ANTIOXIDANTS; BIOTRANSFORMATION; DIETARY SUPPLEMENTS; ENZYME INDUCTION; ENZYME INHIBITORS; FLAVONOIDS; FOOD-DRUG INTERACTIONS; GLUTATHIONE TRANSFERASE; HUMANS; LIVER; XENOBIOTICS;

EID: 84870849440     PISSN: 03602532     EISSN: 10979883     Source Type: Journal    
DOI: 10.3109/03602532.2012.713969     Document Type: Review

References (186)

1. Abramovitz, M., Homma, H., Ishigaki, S., Tansey, F., Cammer, W., Listowsky, I. (1988). Characterization and localization of glutathione-S- transferases in rat brain and binding of hormones, neurotransmitters, and drugs. J Neurochem 50:50-57.
2. Adler, V, Yin, Z, Fuchs, SY, Benezra, M, Rosario, L, Tew, KD, et al. (1999). Regulation of JNK signaling by GSTp. EMBO J 18:1321-1334.
3. Aherne, S. A., O'Brien, N. M. (2002). Dietary flavonols: chemistry, food content, and metabolism. Nutrition 18:75-81.
4. Ahmad, H., Li, J. X., Polson, M., Mackie, K., Quiroga, W., Patil, B. S. (2006). Citrus limonoids and flavonoids: enhancement of phase II detoxification enzymes and their potential in chemoprevention. In: Patil, B. S., Turner, N. D., Miller, E. G., Brodbelt, J. S. (Eds.), Potential health benefits of citrus (pp. 130-143). Washington, DC: American Chemical Society.
5. Ahmad, R., Srivastava, A. K. (2008). Inhibition of filarial glutathione-Stransferase by various classes of compounds and their evaluation as novel antifilarial agents. Helminthologia 45:114-120.
6. Ansell, P. J., Espinosa-Nicholas, C., Curran, E. M., Judy, B. M., Philips, B. J., Hannink, M., et al. (2004). In vitro and in vivo regulation of antioxidant response element-dependent gene expression by estrogens. Endocrinology 145:311-317.
7. Apati, P., Houghton, P. J., Kite, G., Steventon, G. B., Kery, A. (2006). In-vitro effect of flavonoids from Solidago canadensis extract on glutathione S-transferase. J Pharm Pharmacol 58:251-256.
8. Appelt, L. C., Reicks, M. M. (1999). Soy induces phase II enzymes but does not inhibit dimethylbenz(a)antracene-induced carcinogenesis in female rats. J Nutr 129:1820-1826.
9. Armstrong, R. N. (1997). Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem Res Toxicol 10:2-18.
10. Artali, R., Beretta, G., Morazzoni, P., Nomnardelli, E., Meneghetti, F. (2009). Green tea catechins in chemoprevention of cancer. A molecular docking inestigation into their ineraction with glutathione S-transferase GSTP1-1. J Enzyme Inhib Med Chem 24:287-295.
11. Awasthi, S. K., Mishra, N., Dixit, S. K., Singh, A., Yadav, M., Yadav, S. S., et al. (2009). Antifilarial activity of 1,3-diarylpropen-1-one: effect on glutathione-S-transferase, a phase II detoxification enzyme. Am J Trop Med Hyg 80:764-768.
12. Awasthi, Y. C., Yang, Y., Tiwari, N. K., Patrick, B., Sharma, A., Li, J., et al. (2004). Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 37:607-619.
13. Atkinson, H. J., Babbitt, P. C. (2009). Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry 48:11108-11116.
14. Axarli, I. A., Rigden, D. J., Labrou, N. E. (2004). Characterization of the ligandin site of maize glutathione S-transferase I. Biochem J 382:885-893.
15. Barnouin, K., Leier, I., Jedlitschky, G., Pourtier-Manzanedo, A., Konig, J., Lehmann, W. D., et al. (1998). Multidrug resistance proteinmediated transport of chlorambucil and melphalan conjugated to glutathione. Br J Cancer 77:201-209.
16. Bartholomaeus, A. R., Bolton, R., Ahokas, J. T. (1994). Inhibition of rat liver cytosolic glutathione S-transferase by silybin. Xenobiotica 24:17-24.
17. Bayram, B., Ozcelik, B., Grimm, S., Roeder, T., Schrader, C., Ernst, I. M. A., et al. (2012). A diet rich in olive phenolics reduces oxidative stress in the heart of SAMP8 mice by induction of Nrf2-dependent gene expression. Rejuv Res 15:71-81.
18. Beecher, G. R. (2003). Overview of dietary flavonoids: nomenclature, occurrence and intake. J Nutr 133:3248S-3254S.
19. Beuckmann, C. T., Fujimori, K., Urade, Y., Hayaishi, O. (2000). Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem Res 25:733-738.
20. Bhatia, K., Rahman, S., Ali, M., Raisuddin, S. (2006). In vitro antioxidant activity of Juglans regia bark extract and its protective effect on cyclophosphamide-induced urotoxicity in mice. Redox Rep 6:273-279.
21. Boots, A. W., Haenen, G. R., Bast, A. (2008). Health effects of quercetin: from antioxidant to nutraceutical. Eur J Pharmacol 585:325-337.
22. Boušova, I., Hajek, J., Dršata, J., Skalova, L. (2012). Naturally occurring flavonoids as inhibitors of purified cytosolic glutathione S-transferase. Xenobiotica 2012 Mar 30. [Epub ahead of print]
23. Cabrera, M, Lavaggi, ML, Croce, F, Celano, L, Thomson, L, Pintos, C, et al. (2010). Identification of chalcones as in vivo liver monofunctional phase II inducers. Bioorg Med Chem 18:5391-5399.
24. Campling, B. G., Baer, K., Baker, H. M., Lam, Y. M., Cole, S. P. (1993). Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines? Br J Cancer 68:327-335.
25. Castro-Caldas, M., Milagre, I., Rodrigues, E., Gama, M. J. (2009). Glutathione S-transferase pi regulates UV-induced JNK signaling in SH-SY5Y neuroblastoma cells. Neurosci Lett 451:241-245.
26. Cermak, R. (2008). Effect of dietary flavonoids on pathways involved in drug metabolism. Expert Opin Drug Metab Toxicol 4:17-35.
27. Chang, H. C., Chen, H. W., Tung, H. S., Liu, K. L., Tsai, C. W., Li, C. K. (2010). Butein up-regulates the expression of the pi class of glutathione S-transferase in rat primary hepatocytes through the ERK/AP-1 pathway. J Agric Food Chem 58:8994-9000.
28. Chaudhary, P., Sharma, R., Sharma, A., Vatsyayan, R., Yadav, S., Singhal, S. S., et al. (2010). Mechanisms of 4-hydroxy-2-nonenal induced pro-and anti-apoptotic signaling. Biochemistry 49:6263-6275.
29. Chen, W. Y., Hsieh, Y. A., Tsai, C. I., Kang, Y. F., Chang, F. R., Wu, Y. C., et al. (2011). Protoapigenone, a natural derivative of apigenin, induces mitogen-activated protein kinase-dependent apoptosis in human breast cancer cells associated with induction of oxidative stress and inhibition of glutathione S-transferase π. Invest New Drugs 29:1347-1359.
30. Chen, C., Yu, R., Owuor, E. D., Kong, A. N. T. (2000). Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch Pharm Res 23:605-612.
31. Cheng, J. Z., Singhal, S. S., Sharma, A., Saini, M., Yang, Y., Awasthi, S., et al. (2001). Transfection of mGSTA4 in HL-60 cells protects against 4-hydroxynonenal-induced apoptosis by inhibiting JNKmediated signaling. Arch Biochem Biophys 392:197-207.
32. Chow, H. H., Hakim, I. A., Vining, D. R., Crowell, J. A., Tome, M. E., Ranger-Moore, J., et al. (2007). Modulation of human glutathione S-transferases by Polyphenon E intervention. Cancer Epidemiol Biomarkers Prev 16:1662-1666.
33. Cipak, L., Berczeliova, E., Paulikova, H. (2003). Effects of flavonoids on glutathione a glutathione-related enzymes in cisplatin-treated L1210 leukemia cells. Neoplasma 50:443-446.
34. Cirico, T. L., Omaye, S. T. (2006). Additive or synergetic effects of phenolic compounds on human low density lipoprotein oxidation. Food Chem Toxicol 44:510-516.
35. Coles, B. F., Kadlubar, F. F. (2005). Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol 401: 9-42.
36. Conklin, D. J., Haberzettl, P., Lesgards, J. F., Srivastava, S., Bhatnagar, A. (2009). Increased sensitivity of glutathione S-transferase P-null mice to cyclophosphamide-induced urinary bladder toxicity. J Pharm Pharmacol Exp Ther 331:456-469.
37. Cushnie, T. P., Lamb, A. J. (2005). Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26:343-356.
38. Das, M., Singh, S. V., Mukhtar, H., Awasthi, Y. C. (1986). Differential inhibition of rat and human glutathione S-transferase isoenzymes by plant phenols. Biochem Biophys Res Commun 141:1170-1176.
39. Das, S., Roy, P., Auddy, R. G., Mukherjee, A. (2011). Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity. Int J Nanomed 6:1291-1301.
40. de Lange, D. W., Verhoef, S., Gorter, G., Kraaijenhagen, R. J., van de Wiel, A., Akkerman, J. W. (2007). Polyphenolic grape extract inhibits platelet activation through PECAM-1: an explanation for the French paradox. Alcohol Clin Exp Res 31:1308-1314.
41. Den Boer, M. L., Pieters, R., Kazemier, K. M., Henze, G., Kaspers, G. J. L., Kearns, P. R., et al. (1999). Different expression of glutatione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukemia. Br J Haematol 104:321-327.
42. Dewick, P. M. (2002). Medicinal natural products, a biosynthetic approach. Chichester, UK: John Wiley & Sons.
43. Dorion, S., Lambert, H., Landry, J. (2002). Activation of the p38 signaling pathway by heat shock involves the dissociation of glutathione S-transferase Mu from Ask1. J Biol Chem 277:30792-30797.
44. Dourado, D. F., Fernandes, P. A., Ramos, M. J. (2008). Mammalian cytosolic glutathione transferases. Curr Protein Pept Sci 9:325-337.
45. Durgo, K., Vukovic, L., Rusak, G., Osmak, M., Colic, J. F. (2009). Cytotoxic and apoptotic effect of structurally similar flavonoids on parental and drug-resistant cells of human cervical carcinoma. Food Technol Biotechnol 47:356-363.
46. Ebert, M. N., Klinder, A., Peters, W. H., Schaferhenrich, A., Sendt, W., Scheele, J., et al. (2003). Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 24:1637-1644.
47. Egert, S., Rimbach, G. (2011). Which sources of flavonoids: complex diets or dietary supplements? Adv Nutr 2:8-14.
48. Ekhart, C., Doodeman, V. D., Rodenhuis, S., Smits, P., Beijnen, J. H., Huitema, A. D. R. (2009). Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6, and CYP3A) affect the pharmacokinetics of thiotepa and tepa. Br J Clin Pharmacol 67:50-60.
49. Fernandez-Canon, J. M., Penalva, M. A. (1998). Characterization of a fungal maleylacetoacetate isomerase gene and identification of its human homologue. J Biol Chem 273:329-337.
50. Ferreira, D., Slade, D., Marais, J. P. J. (2006). Flavans and proanthocyanidins. In: Andersen, O. M., Markham, K. R. (Eds.), Flavonoids: chemistry, biochemistry, and applications (pp. 553-617). Boca Raton, Florida, USA: CRC.
51. Frova, C. (2006). Glutathione transferases in the genomics era: new insights and perspectives. Biomol Eng 23:149-169.
52. Froyen, E. B., Reeves, J. L. R., Mitchel, A. E., Steinberg, F. M. (2009). Regulation of phase II enzymes by genistein and daidzein in male and female Swiss Webster mice. J Med Food 12:1227-1237.
53. Gilbert, L., Elwood, L. J., Merino, M., Masood, S., Barnes, R., Steinberg, S. M., et al. (1993). A pilot study of pi-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J Clin Oncol 11:49-58.
54. Goh, K., Chen, Y., Zheng, L., Ong, L., Jin, Y., Chow, P., et al. (2008). 2,2'-Dihydroxychalcone, a glutathione transferase inhibitor, sensitises human colon adenocarcinoma cells to chlorambucil and melphalan, but not to actinomycin D. Mol Med Report 4:575-579.
55. Gong, Y., Han, C., Chen, J. (2000). Effect of tea polyphenols and tea pigments on the inhibition of precancerous liver lesions in rats. Nutr Cancer 38:81-86.
56. Halliwell, B. (2007). Dietary polyphenols: good, bad, or indifferent for your health? Cardiovasc Res 73:341-347.
57. Halliwell, B. (2008). Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 476:107-112.
58. Hanušova, V., Boušova, I., Skalova, L. (2011). Possibilities to increase the effectiveness of doxorubicin in cancer cells killing. Drug Metab Rev 43:540-557.
59. Hayes, J. D., Flanagan, J. U., Jowsey, I. R. (2005). Glatathione transferases. Annu Rev Pharmacol Toxicol 45:51-88.
60. Hayes, J. D., McMahon, M. (2001). Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett 174:103-113.
61. Hayes, P. C., Bouchier, I. A. D., Beckett, G. J. (1991). Glutathione S-transferase in humans in health and disease. Gut 32:813-818.
62. Hayeshi, R., Mutingwende, I., Mavengere, W., Masiyanise, V., Mukanganyama, S. (2007). The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin. Food Chem Toxicol 45:286-295.
63. Higgins, L. G., Hayes, D. (2011). Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflamatory agents. Drug Metab Rev 43:92-137.
64. Horton, J. K., Roy, G., Piper, J. T., Van Houten, B., Awasthi, Y. C., Mitra, S., et al. (1999). Characterization of a chlorambucil-resistant human ovarian carcinoma cell line overexpressing glutathione S-transferase mu. Biochem Pharmacol 58:693-702.
65. Hubatsch, I., Ridderstrom, M., Mannervik, B. (1998). Human glutathione transferase A 4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem J 330:175-179.
66. Hubbard, G. P., Wolffram, S., Lovegrove, J. A., Gibbins, J. M. (2004). Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans. J Thromb Haemost 2:2138-2145.
67. Hurst, R., Bao, Y., Jemth, P., Mannervik, B., Williamson, G. (1998). Phospholipid hydroperoxide glutathione transferase activity of human glutathione transferases. Biochem J 332:97-100.
68. Iio, M., Kawaguchi, H., Sakota, Y., Otonari, J., Nitahara, H. (1993). Effects of polyphenols, including flavonoids, on glutathione S-transferase and glutathione reductase. Biosci Biotechnol Biochem 57:1678-1680.
69. Jakobsson, P. J., Morgenstern, R., Mancini, J., Ford-Hutchinson, A., Persson, B. (1999a). Common structural features of MAPEG-a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism. Protein Sci 8:689-692.
70. Jakobsson, P. J., Thoren, S., Morgenstern, R., Samuelsson, B. (1999b). Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 96:7220-7225.
71. Johansson, A. S., Mannervik, B. (2001). Human glutathione transferase A3-3, a highly efficient catalyst of double-bond isomerization in the biosynthetic pathway of steroid hormones. J Biol Chem 276:33061-33065.
72. Jodynis-Liebert, J., Matlawska, I., Bylka, W., Murias, M. (2005). Protective effect of Aquilegia vulgaris on APAP-induced oxidative stress in rats. J Ethnopharmacol 97:351-358.
73. Jovanovic, S. V., Steenken, S., Tosic, M., Marjanovic, B., Simic, M. G. (1994). Flavonoids as antioxidants. J Am Chem Soc 116:4846-4851.
74. Jowsey, I. R., Thomson, A. M., Flanagan, J. U., Murdock, P. R., Moore, G. B., Meyer, D. J., et al. (2001). Mammalian class sigma glutathione S-transferases: catalytic properties and tissue-specific expression of human and rat GSH-dependent prostaglandin D2 synthases. Biochem J 359:507-516.
75. Kang, K. W., Park, E. Y., Kim, S. G. (2003). Activation of CCAAT/enhancer-binding protein beta by 20-amino-30-methoxyflavone (PD98059) leads to the induction of glutathione S-transferase A2. Carcinogenesis 24:475-482.
76. Kessler, M., Ubeaud, G., Jung, L. (2003). Anti-and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 55:131-142.
77. Ketley, J. N., Habig, W. H., Jakoby, W. B. (1975). Binding of nonsubstrate ligands to the glutathione S-transferases. J Biol Chem 250:8670-8673.
78. Khatiwada, J., Verghese, M., Walker, L. T., Shackelford, L., Chawan, C. B., Sunkura, R. (2006). Combination of green tea, phytic acid, and inositol reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. LWT-Food Sci Technol 39:1080-1086.
79. Kim, Y. W., Kang, H. E., Lee, M. G., Hwang, S. J., Kim, S. C., Lee, C. H., et al. (2009). Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase II enzymes. Am J Physiol 296:G372-G381.
80. Kohno, H., Tanaka, T., Kawabata, K., Hirose, Y., Sugie S., Tsuda H., et al. (2002). Silymarin, a naturally occurring polyphenolic antioxidant flavonoid, inhibits azoxymethane-induced colon carcinogenesis in male F344 rats. Int J Cancer 101:461-468.
81. Kolobe, D., Sayed, Y., Dirr, H. W. (2004). Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics. Biochem J 382:703-709.
82. Kong, A. N. T, Yu, R., Hebbar, V., Chen, C., Owuor, E., Hu, R., et al. (2001). Signal transduction events elicited by cancer prevention compounds. Mutat Res 480:231-241.
83. Kupeli, E., Orhan, D., Yeslida, E. (2006). Effect of Cistus laurifolius L leaf extracts and flavonoids on acetaminophen-induced hepatotoxiciy in mice. J Ethnopharmacol 103:455-460.
84. Laborde, E. (2010). Glutathione transferases as mediators of signaling pathways involved in cell proliferation and cell death. Cell Death Differ 17:1373-1380.
85. Li, N., Muthusamy, S., Liang, R. Q., Sarojini, H., Wang, E. (2011). Increased expression of miR-34a and miR-93 in rat liver during aging and their impact on the expression of mGST1 and Sirt1. Mechan Ageing Dev 132:75-85
86. Lucena, M. I., Andrade, R. J., Martinez, C., Ulzurrun, E., Castiell, A., Planas, R., et al. (2008). Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology 48:588-596.
87. Lyon, R. P., Atkins, W. M. (2002). Kinetic characterization of native and cysteine 112-modified glutathione S-transferase A1-1: reassessment of nonsubstrate ligand binding. Biochemistry 41:10920-10927.
88. Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., Kliewe, S. A. (2002). Nucler pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol 62:638-646
89. Mahajan, S., Atkins, W. M. (2005). The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases. Cell Mol Life Sci 62:1221-1233.
90. Maliakal, P. P., Coville, P. F., Wanwimolruk, S. (2001). Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats. J Pharm Pharmacol 53:569-577.
91. Mannervik, B., Board, P. G., Hayes, J. D., Listowsky, I., Pearson, W. R. (2005). Nomenclature for mammalian soluble glutathione transferases. Methods Enzymol 401:1-8.
92. Mandlekar, S., Hong, J. L., Kong, A. N. T. (2006). Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects. Curr Drug Metab 7:661-675.
93. Mathew, N., Kalyanasundaram, M., Balaraman, K. (2006). Glutathione S-transferase (GST) inhibitors. Expert Opin Ther Pat 16:431-444.
94. McLellan, L. I., Wolf, C. R. (1999). Glutathione and glutathionedependent enzymes in cancer drug resistance. Drug Resist Updat 2:153-164.
95. McMahon, M., Itoh, K., Yamamoto, M., Chanas, S. A., Henderson, C. J., McLellan, L. I., et al. (2001). The Cap n Collar basic leucine zipper transcription factor Nrf2 (NF-E2p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res 61:3299-3307.
96. Merlos, M., Sanchez, R. M., Camarasa, J., Adzet, T. (1991). Flavonoids as inhibitors of rat liver cytosolic glutathione S-transferase. Experientia 47:616-619.
97. Mesia-Vela, S., Kauffman, F. C. (2003). Inhibition of rat liver sulfotransferases SULT1A1 and SULT2A1 and glucuronosyltransferase by dietary flavonoids. Xenobiotica 33:1211-1220.
98. Metodiewa, D., Jaiswal, A. K., Cenas, N., Dickancaite, E., Segura-Aguilar, J. (1999). Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic Biol Med 26:107-116.
99. Middleton, E., Jr., Kandaswami, C., Theoharides, T. C. (2000). The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673-751.
100. Mira, L., Fernandez, M. T., Santos, M., Rocha, R., Florencio, M. H., Jennings, K. R. (2002). Interactions of flavonoids with iron and copper ions: a mechanism for their antioxidant activity. Free Radic Res 36:1199-1208.
101. Mishra, A., Chandra, R., Mehrotra, P. K., Agrawal, D. (2011). Glutathione S-transferase M1 and T1 polymorphism and respose to neoadjuvant chemotherapy (CAF) in breast cancer patients. Surg Today 4:471-476.
102. Mitchell, A. E., Burns, S. A., Rudolf, J. L. (2007). Isoenzyme-and genderspecific induction of glutathione S-transferases by flavonoids. Arch Toxicol 81:777-784.
103. Miyanishi, K., Takayama, T., Ohi, M., Hayashi, T., Nobuoka, A., Nakajima, T., et al. (2001). Glutathione S-transferase-pi overexpression is closely associated with K-ras mutation during human colon carcinogenesis. Gastroenterology 121:865-874.
104. Moon, Y. J., Wang, X., Morris, M. E. (2006). Dietary flavonoids: effect on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20:187-210.
105. Morales, G. A., Laborde, E. (2007). Small-molecule inhibitors of glutathione S-transferase P1-1 as anticancer therapeutic agents. Annu Rep Med Chem 42:321-335.
106. Morel, F., Rauch, C., Petit, E., Piton, A., Theret, N., Coles, B., et al. (2004). Gene and protein characterization of the human glutathione S-transferase kappa and evidence for a peroxisomal localization. J Biol Chem 279:16246-16253.
107. Nagaprashantha, L. D., Vatsyayan, R., Singhal, J., Lelsani, P., Prokai, L., Awasthi, S., et al. (2011). 2'-hydroxyflavanone inhibits proliferation, tumor vascularization, and promotes normal differentiation in VHL-mutant renal cell carcinoma. Carcinogenesis 32:568-575.
108. Nakatsuma, A., Fukami, T., Suzuki, T., Furushi, T., Tomono, K., Hidaka, S. (2010). Effects of kaempferol on the mechanisms of drug resistence in the human glioblastoma cell line T98G. Pharmazie 65:379-383.
109. Nijhoff, W. A., Bosboom, M. A., Smidt, M. H., Peters, W. H. M. (1995). Enhancement of rat hepatic and gastrointestinal glutathione S-transferase by α-angelicalactone and flavones. Carcinogenesis 16:607-612.
110. Nishimura, M., Naito, S. (2006). Tissue-specific mRNA expression profiles of human phase I metabolizing enzymes except for cytochrome P450 and phase II metabolizing enzymes. Drug Metab Pharmacokinet 21:357-374.
111. Noguchi, K., Katayama, K., Mitsuhashi, J., Sugimoto, Y. (2009). Functions of breast cancer resistence protein (BCRP/ABCG2) in chemotherapy. Adv Drug Delivery Rev 61:26-33.
112. Oakley, A. J., Lo Bello, M., Nuccetelli, M., Mazzetti, A. P., Parker, M. W. (1999). The ligandin (non-substrate) binding site of human Pi class glutathione transferase is located in the electrophile binding site (H-site). J Mol Biol 291:913-926.
113. Oakley, A. (2011). Glutathione transferases: a structural perspective. Drug Metab Rev 43:138-151.
114. Oliveira, A. L., Rodrigues, F., Santos, R., Rocha, M., Longui, C., Melo, M. B. (2010). GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer. Gen Mol Res 9:1045-1053.
115. Owuor, E. D., Kong, A. T. (2002). Antioxidants and oxidants regulated signal transduction pathways. Biochem Pharmacol 64:765-770.
116. Oz, H. S., McClain, C. J., Nagasawa, H. T., Ray, M. B., de Williers, W., Chen, T. S. (2004). Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol 8:361-368.
117. Parkinson, A. (2001). Biotransformation of xenobiotics. In: Klaassen, C. D. (Ed.) Casarett & Doull's toxicology: the basic science of poisons (pp. 133-224). New York: McGraw-Hill.
118. Parvez, S., Tabassum, H., Rehman, H., Basu, D., Athar, M. (2006). Catechin prevents tamoxifen-induced oxidative stress and biochemical perturbations in mice. Toxicology 225:109-118.
119. Peklak-Scott, C., Townsend, A. J., Morrow, C. S. (2005). Dynamics of glutathione conjugation and conjugate efflux in detoxification of the carcinogen, 4-nitroquinoline 1-oxide: contributions of glutathione, glutathione S-transferase, and MRP1. Biochemistry 44:4426-4433.
120. Pemble, S. E., Wardle, A. F., Taylor, J. B. (1996). Glutathione S-transferase class kappa: characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 319:749-754.
121. Peters, W. H., Wormskamp, N. G., Thies, E. (1990). Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis 11:1593-1596.
122. Pietta, P. G. (2000). Flavonoids as antioxidants. J Nat Prod 63:1035-1042.
123. Polekhina, G., Board, P. G., Blackburn, A. C., Parker, M. W. (2001). Crystal structure of maleylacetoacetate isomerase/glutathione transferase zeta reveals the molecular basis for its remarkable catalytic promiscuity. Biochemistry 40:1567-1576.
124. Poonkuzhali, B., Chandy, M., Srivastava, A., Dennison, D., Krishnamoothry, R. (2001). Glutathione S-transferase activity influences busulfan pharmacokinetics in patients undergoing bone marrow transplantation. Drug Metab Dispos 29:264-267.
125. Prade, L., Huber, R., Manoharan, T. H., Fahl, W. E., Reuter, W. (1997). Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor. Structure 5:1287-1295.
126. Prochazkova, D., Boušova, I., Wilhelmova, N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia 82:513-523.
127. Raijmakers, M. T. M., Steegers, E. A. P., Peters, W. H. M. (2001). Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 16:2445-2450.
128. Ramos-Gomez, M., Kwak, M. K., Dolan, P. M., Itoh, K., Yamamoto, M., Talalay, P., et al. (2001). Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci USA 98:3410-3415.
129. Rathaur, S., Yadav, M., Singh, N., Singh, A. (2011). Effect of diethylcarbamazine, butylated hydroxy anisole, and methyl substituted chalcone on filarial parasite Setaria cervi: proteomic and biochemical approaches. J Proteomics 74:1595-1606.
130. Rea, V., Dragovic, S., Boerma, J. S., de Kanter, F., Vermeulen, N. P. E., Commandeur, J. N. M. (2011). Application for structural characterization of clozapine GSH conjugates. Drug Metab Dispos 39:2411-2420.
131. Renugadevi, J., Prabu, S. M. (2010). Cadmium-induced hepatotoxicity in rats and the protective effect of naringenin. Exp Toxicol Pathol 62:171-181.
132. Rice-Evans, C. A., Miller, N. J., Paganga, G. (1996). Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic Biol Med 20:933-956.
133. Rodeiro, I., Donato, M. T., Lahoz, A., Garrido, G., Delgado, R., Gomez-Lechon, M. J. (2008). Interactions of polyphenols with the P450 system: possible implications on human therapeutics. Mini Rev Med Chem 8:97-106.
134. Romero, L., Andrews, K., Ng, L., O'Rourke, K., Maslen, A., Kirby, G. (2006). Human GSTA1-1 reduces c-Jun N-terminal kinase signalling and apoptosis in Caco-2 cells. Biochem J 400:135-141.
135. Rudolf, J. L., Bauerly, K. A., Tchaparian, E., Rucker, R. B., Mitchell, A. E. (2008). The influence of diet composition on phase I and II biotransformation enzyme induction. Arch Toxicol 82:893-901.
136. Ruzza, P., Rosato, A., Rossi, C. R., Floreani, M., Quintieri, L. (2009). Glutathione transferases as targets for cancer therapy. Anticancer Agents Med Chem 9:763-777.
137. Ryoo, K., Huh, S. H., Lee, Y. H., Yoon, K. W., Cho, S. G., Choi, E. J. (2004). Negative regulation of MEKK1-induced signaling by glutathione S-transferase mu. J Biol Chem 279:43589-3594.
138. Sau, A., Tregno, F. P., Valentino, F., Federici, G., Caccuri, A. C. (2010). Glutathione transferases and development of new principles to overcome drug resistance. Arch Biochem Biophys 500:116-122.
139. Sau, A., Filomeni, G., Pezzola, S., D'Aguanno, S., Tregno, F. P., Urbani, A., et al. (2012). Targeting GSTP1-1 induces JNK activation and leads to apoptosis in cisplatin-sensitive and-resistant human osteosarcoma cell lines. Mol BioSyst 8:994-1006.
140. Sahu, S. C., Gray, G. C. (1996). Pro-oxidant activity of flavonoids: effects on glutathione and glutathione S-transferase in isolated rat liver nuclei. Cancer Lett 104:193-196.
141. Seeley, S. K., Poposki, J. A., Maksimchuk, J., Tebbe, J., Gaudreau, J., Mannervik, B., et al. (2006). Metabolism of oxidized linoleic acid by glutathione transferases: peroxidase activity toward 13- hydroperoxyoctadecadienoic acid. Biochim Biophys Acta 1760:1064-1070.
142. Sharda, S. V., Gulati, S., Tripathi, G., Jafar, T., Sharma, R., Agrawal, S. (2008). Do glutathione S-transferases polymorphisms influence response to intravenous cyclophosphamide therapy in idiopathic nephritic syndrome? Ped Nephrol 11:2001-2006.
143. Sharma, N., Trikha, P., Athar, M., Raisuddin, S. (1999). Protective effect of Cassia occidentalis extract on chemical-induced chromosomal aberrations in mice. Drug Chem Toxicol 22:643-653.
144. Simnek, T., Sterba, M., Popelova, O., Adamcova, A., Hrdina, R., Gersl, V. (2009). Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. Pharmacol Reports, 61, 154-71.
145. Srinivasan, L., Mathew, N., Muthuswamy, K. (2009). In vitro antifilarial activity of glutathione S-transferase inhibitors. Parasitol Res 105:1179-1182.
146. Srivastava, A., Poonkuzhali, B., Shaji, R. V., Mathews, V., Chandy, M., Krishnamoorthy, R. (2004). Glutathione S-transferase M1 polymorphism: a risk factor for hepatic venooclusive disease in bone marrow transplantation. Blood 104:1574-1577.
147. Staedler, D., Idrizi, E., Kenzaoui, B. H., Juillerat-Jeanneret, L. (2011). Drug combination with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemotherap Pharmacol 68:1161-1172.
148. Subramanian, R., Fang, X., Prueksaritanont, T. (2002). Structural characterization of in vivo rat glutathione adducts and a hydroxylated metabolite of simvastatin hydroxy acid. Drug Metab Dispos 30:225-230.
149. Suganuma, M., Saha, A., Fujiki, H. (2011). New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sci 102:317-323.
150. Svehlikova, V., Wang, S., Jakubikova, J., Williamson, G., Mithen, R., Bao, Y. (2004). Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells. Carcinogenesis 25:1629-1637.
151. Tanaka, T., Kawabata, K., Kakumoto, M., Makita, H., Ushida, J., Honjo, S., et al. (1999). Modifying effects of flavonoid morin on azoxymethane-induced large bowel tumorigenesis in rats. Carcinogenesis 20:1477-1484.
152. Testa, B., Kramer, S. D. (2010). The biochemistry of drug metabolism: conjugations, consequences of metabolism, influencing factors. Zurich, Switzerland: Willey-VCH.
153. Tew, K. D., Dutta, S., Shultz, M. (1997). Inhibitors of glutatione S-tranferases as therapeutic agents. Adv Drug Deliv Rev 26:91-104.
154. Tew, K. D., Manevich, Y., Grek, C., Xiong, Y., Uys, J., Townsend, D. M. (2011). The role of glutathione S-transferase P in signaling pathways and S-glutathionylation in cancer. Free Radic Biol Med 51:299-313.
155. Tew, K. D., Monks, A., Barone, L., Rosser, D., Akerman, G., Montali, J. A., et al. (1996). Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program. Mol Pharmacol 50:149-159.
156. Tiku, A. B., Abraham, S. K., Kale, R. K. (2008). Protective effect of the cruciferous vegetable mustard leaf against in vivo chromosomal damage and oxidative stress induced by gamma radiation and genotoxic chemicals. Environ Mol Mutagen 49:335-342.
157. Tomas-Barberan, F. A., Clifford, M. N. (2000). Flavanones, chalcones and dihydrochalcones-nature, occurrence, and dietary burden. J Sci Food Agric 80:1073-1080.
158. Torres-Rivera, A., Landa, A. (2008). Glutathione transferases from parasites: a biochemical view. Acta Trop 105:99-112.
159. Townsend, D. M., Findlay, V. L., Tew, K. D. (2005). Glutathione S-transferases as regulators of kinase pathways and anticancer drug targets. Methods Enzymol 401:287-307.
160. Townsend, D. M., Tew, K. D. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369-7375.
161. Townsend, D. M., Manevich, Y., He, L., Hutchens, S., Pazoles, C. J., Tew, K. D. (2009). Novel role for glutathione S-transferase pi. Regulator of protein S-glutathionylation following oxidative and nitrosative stress. J Biol Chem 284:436-445.
162. Uetrecht, J. P., Trager, W. (2007). Drug metabolism: chemical and enzymatic aspects. New York: Informa Healthcare.
163. Uzun, F. G., Demir, F., Kalendar, S., Bas, H., Kalendar, Y. (2010). Protective effect of catechins and quercetin on chlorpyrifos-induced lung toxicity in male rats. Food Chem Toxicol 48:1714-1720.
164. van Bladeren, P. J. (2000). Glutathione conjugation as a bioactivation reaction. Chem Biol Interact 129:61-76.
165. van Bladeren, P. J., van Ommen, B. (1991). The inhibition of glutathione
166. van Lieshout, E. M. M., Bedaf, M. M. G., Ekkel, M. P. C., Nijhoff, W. A., Peters, W. H. M. (1998). Effects of dietary anticarcinogens on rat gastrointestinal glutathione S-transferase theta 1-1 levels. Carcinogenesis 19:2055-2057.
167. van Zanden, J. J., Ben Hamman, O., van Lersel, M. L. P. S., Boeren, S., Cnubben, N. H. P., Lo Bello, M., et al. (2003). Inhibition of human glutathione S-transferase P1-1 by the flavonoid quercetin. Chem Biol Interact 145:139-148.
168. van Zanden, J. J., Geraets, L., Wortelboer, H. M., van Bladeren, P. J., Rietjens, I. M., Cnubben, N. H. (2004). Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells. Biochem Pharmacol 67:1607-1617.
169. Veitch, N. C., Grayer, R. J. (2006). Chalcones, dihydrochalcones, and aurones. In: Andersen, O. M., Markham, K. R. (Eds.), Flavonoids: chemistry, biochemistry, and applications (pp. 1003-1100). Boca Raton, Florida, USA: CRC.
170. Waldon, D. J., Teffera, Y., Colleti, A., Liu, J., Zucher, D., Copeland, K., et al. (2010). Identification of quinine imine containing glutathione conjugates of diclofenac in rat bile. Chem Res Toxicol 23:1947-1953.
171. Wang, J., Zhang, W., Zhu, D., Zhu, X., Pang, X., Qu, W. (2011). Hypolipidaemic and hypoglycaemic effects of total flavonoids from seed residues of Hippophae rhamnoides L. in mice fed a high-fat diet. J Sci Food Agric 91:1446-1451.
172. Wang, T., Arifoglu, P., Ronai, Z., Tew, K. D. (2001). Glutathione S-transferase P1-1 (GSTP1-1) inhibits c-Jun N-terminal kinase (JNK1) signaling through interaction with the C terminus. J Biol Chem 276:20999-21003.
173. Whitbread, A. K., Tetlow, N., Eyre, H. J., Sutherland, G. R., Board, P. G. (2003). Characterization of the human omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics 13:131-144.
174. Wiegand, H., Boesch-Saadatmandi, C., Regos, I., Treuter, D., Wolffram, S., Rimbach, G. (2009a). Effects of quercetin and catechin on hepatic glutathione-S-transferase (GST), NAD(P)H quinone oxidoreductase 1 (NQO1), and antioxidant enzyme activity levels in rats. Nutr Cancer 61:717-722.
175. Wiegand, H., Wagner, A. E., Boesch-Saadatmandi, C., Kruse, H. P., Kulling, S., Rimbach, G. (2009b). Effect of dietary genistein on phase II and antioxidant enzymes in rat liver. Cancer Genomics Proteomics 6:85-92.
176. Williams, C. A., Grayer, R. J. (2004). Anthocyanins and other flavonoids. Nat Prod Rep 21:539-573.
177. Winkel-Shirley, B. (2001). Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol 126:485-493.
178. Wu, G., Vashishtha, S. C., Erve, J. C. L. (2010). Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches. Chem Res Toxicol 23:1393-1404.
179. Wu, Y., Fan, Y., Xue, B., Luo, L., Shen, J., Zhang, S., et al. (2006). Human glutathione S-transferase P1-1 interacts with TRAF2 and regulates TRAF2-ASK1 signals. Oncogene 25:5787-5800.
180. Xu, C., Li, C. Y., Kong, A. N. T. (2005). Induction of phase I, II, and III drug metabolism/transport by xenobiotics. Arch Pharm Res 28:249-268.
181. Yin, Z. L., Dahlstrom, J. E., Le Couteur, D. G., Board, P. G. (2001). Immunohistochemistry of omega class glutathione S-transferase in human tissues. J Histochem Cytochem 49:983-987.
182. Zhang, K., Das, N. P. (1994). Inhibitory effects of plant polyphenols on rat liver glutathione S-transferases. Biochem Pharmacol 47:2063-2068.
183. Zhang, Y., Gordon, G. B. (2004). A strategy for cancer prevention: stimulation of the Nrf2-ARE signaling pathway. Mol Cancer Ther 3:885-893.
184. Zhang, K., Wong, K. P., Chow, P. (2003). Conjugation of chlorambucil with GSH by GST purified from human colon adenocarcinoma cells and its inhibition by plant polyphenols. Life Sci 72:2629-2640.
185. Zhao, T. J., Singhal, S. S., Piper, J. T., Cheng, J. Z., Pandya, U., Clark-Wronski, J., et al. (1999). The role of human glutathione S-transferases hGSTA1-1 and hGSTA2-2 in protection against oxidative stress. Arch Biochem Biophys 367:216-224.
186. Zieliska, E., Bodalski, J. (2001). Growth retardation and osteomalacia as a result of ifosfamide nephrotoxicity in a 3-year-old boy whose genotype revers the genes enconding GSTM1 and GSTT1. Cytobios 106:193-200.